Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH – Reuters

Business News

  1. Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH  Reuters
  2. Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis  PR Newswire
  3. Novo Nordisk’s obesity drug Wegovy cleared to treat MASH  statnews.com
  4. Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH  Yahoo Finance
  5. Novo Nordisk’s Wegovy Gets US Approval for Liver Disease  Bloomberg.com

Source: Business News

/by